1-4 of 4
Ryunosuke Machida
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Role of bortezomib maintenance therapy in the anti-CD38 antibody era: Interim analysis results of a randomized Phase III study for transplant-ineligible newly diagnosed multiple myeloma (JCOG1911/B-DASH Study)

Free
Tomotaka Suzuki, Ryunosuke Machida, Yusuke Sano, Kazuyuki Shimada, Shinsuke Iida, Nobuhiko Yamauchi, Nobuhiko Nakamura, Hiroshi Handa, Yoshikazu Hori, Yasuhiro Suzuki, Daisuke Ogiya, Keisuke Kataoka, Eiji Negoro, Hiroyuki Takahashi, Junya Kuroda, Junya Makiyama, Ichiro Hanamura, Kaname Miyashita, Satoshi Ito, Hideki Uryu, Shigeru Kusumoto, Masahiro Takeuchi, Yasuhiro Harada, Takahiro Kumode, Ritsuro Suzuki, Isao Yoshida, Naoko Harada, Wataru Munakata, Hirokazu Nagai, Dai Maruyama
Journal: Blood
Blood (2025) 146 (Supplement 1): 370.
https://doi.org/10.1182/blood-2025-370
Published: 2025
Journal Articles

Randomized Phase III Study of Watchful Waiting Vs. Rituximab As First-Line Treatment in Patients with Advanced Stage Low Tumor Burden Follicular Lymphoma: JCOG1411/Flora Study

Free
Noriko Fukuhara, Dai Maruyama, Kenichi Ishizawa, Yusuke Sano, Ryunosuke Machida, Shinichi Makita, Wataru Munakata, Satoshi Ichikawa, Keiko Aizawa, Kana Miyazaki, Yoshihiro Kameoka, Shinya Rai, Yu Yagi, Naoki Takahashi, Toshiki Mushino, Takeharu Kato, Yuri Miyazawa, Toko Saito, Kazuyuki Shimada, Junya Kuroda, Hideki Uryu, Yuko Mishima, Nobuyuki Takayama, Yasuhiro Suzuki, Toshiki Uchida, Nobuhiko Nakamura, Takayuki Tabayashi, Yosuke Minami, Nobuaki Dobashi, Kunihiro Tsukasaki, Hirokazu Nagai
Journal: Blood
Blood (2024) 144 (Supplement 1): 338.
https://doi.org/10.1182/blood-2024-199868
Published: 2024
Journal Articles

Interim PET-Guided ABVD or ABVD/Escalated BEACOPP for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma (JCOG1305, INNOVATE-HL study)

Free
Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, Takashi Terauchi, Hiroaki Onaya, Masahiko Oguchi, Shinsuke Iida, Kisato Nosaka, Yasuhiro Suzuki, Yasuhiko Harada, Kana Miyazaki, Masaki Maruta, Noriko Fukuhara, Tomomi Toubai, Nobuko Kubota, Ken Ohmachi, Kazuhito Yamamoto, Takahiro Kumode, Ishikazu Mizuno, Takayuki Tabayashi, Hideki Tsujimura, Nobuyuki Takayama, Kohsuke Asagoe, Isao Yoshida, Yasushi Takamatsu, Suguru Fukuhara, Mai Takeuchi, Ukihide Tateishi, Dai Maruyama, Kunihiro Tsukasaki, Hirokazu Nagai
Journal: Blood
Blood (2022) 140 (Supplement 1): 3718–3720.
https://doi.org/10.1182/blood-2022-157006
Published: 2022
Journal Articles

Possibility of a Risk-Adapted Treatment Strategy for Untreated Aggressive Adult T-Cell Leukemia-Lymphoma (ATL) Based on the ATL Prognostic Index: A Supplementary Analysis of the JCOG9801 Study

Free
Kosuke Toyoda, MD, Kunihiro Tsukasaki, MD PhD, Ryunosuke Machida, Tomohiro Kadota, MD PhD, Takuya Fukushima, MD PhD, Kenji Ishitsuka, MD PhD, Dai Maruyama, MD PhD, Hirokazu Nagai, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1645.
https://doi.org/10.1182/blood-2018-99-112734
Published: 2018